- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02656758
Intensive Executive Function Training
October 9, 2016 updated by: ZIli Fan
A Randomized Controlled Study on the Effect of Intensive Functional Training on Children With Attention Deficit Hyperactivity Disorder
The investigators intent to recruit 80 attention deficit hyperactivity disorder families.
The attention deficit hyperactivity disorder families had received executive function training one year before.They will be randomized to intervention group and control group using a block randomization design.
The intervention group will participate in intensive executive function training immediately,while the control group will receive executive training after 3 months.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Peking University Sixth Hospital/Institute of Mental Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- clinical diagnosis of child attention deficit hyperactivity disorder
- full-scale intelligence quotient (FSIQ) ≥70
- stable on medication for attention deficit hyperactivity disorder children at least 3 months
- participation in the early implementation of functional training one year before
Exclusion Criteria:
- individuals with major neurological disorders
- a diagnosis of schizophrenia, epilepsy, mental retardation or other brain disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Executive function training
the experimental group will receive 12 sessions of intensive Executive function training weekly immediately
|
Children diagnosis of attention deficit hyperactivity disorder are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of intensive executive function training weekly no intervention :waiting participants will not be treated with intensive executive function training and keep waiting for 12 weeks for comparison
|
|
Other: the waitlist group
the waitlist group will wait 12 weeks before receiving intensive executive function training for comparison.
|
Children diagnosis of attention deficit hyperactivity disorder are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of intensive executive function training weekly no intervention :waiting participants will not be treated with intensive executive function training and keep waiting for 12 weeks for comparison
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in attention deficit hyperactivity disorder-rating scale
Time Frame: baseline, after the training (12 weeks)
|
baseline, after the training (12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in behavior rating scale of executive function
Time Frame: baseline, after the training (12 weeks)
|
baseline, after the training (12 weeks)
|
|
Cambridge Neuropsychological Test Automatic Battery
Time Frame: baseline, after the training (12 weeks)
|
baseline, after the training (12 weeks)
|
|
Behavior Rating Inventory of Executive Function
Time Frame: baseline, after the training (12week)
|
baseline, after the training (12week)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ying Qian, Peking University Sixth Hospital/Institute of Mental Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
December 1, 2017
Study Completion (Anticipated)
December 1, 2018
Study Registration Dates
First Submitted
January 11, 2016
First Submitted That Met QC Criteria
January 14, 2016
First Posted (Estimate)
January 15, 2016
Study Record Updates
Last Update Posted (Estimate)
October 11, 2016
Last Update Submitted That Met QC Criteria
October 9, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Z151100004015103
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
Clinical Trials on intensive Executive function training
-
University of Missouri, Kansas CityUniversity of KansasUnknownPosttraumatic Stress DisordersUnited States
-
Education University of Hong KongRecruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Completed
-
Concordia University, MontrealCanadian Institutes of Health Research (CIHR)CompletedAging | Age Related Hearing LossCanada
-
Xinhua Hospital, Shanghai Jiao Tong University...Active, not recruitingADHD | Child, OnlyChina
-
Education University of Hong KongActive, not recruitingAutism Spectrum DisorderHong Kong
-
CogCubed, CorpOhio UniversityCompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Asperger's Disorder | Pervasive Developmental DisorderUnited States
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingTBI (Traumatic Brain Injury)United States
-
BaycrestSunnybrook Health Sciences CentreUnknownTransient Ischemic Attack | Mild Stroke | Ischemic White Matter Disease | Stroke RiskCanada